FAQ
The board of directors of Samsung C&T consists of 4 independent directors and 3 executive directors, with independent directors being the majority.
There are 5 committees under the board and all committees are chaired by independent directors except for the Executive Committee.
ㆍSustainability Committee, Independent Director Recommendation Committee, Audit Committee,
Compensation Committee, Executive Committee
Some of the authorities of the Board are delegated to committees to increase efficiency and to empower committee members who have extensive experience and knowledge in the areas of expertise to review and resolve concerned issues.
For further information, please refer to [Sustainability > Governance > Board of Directors].
Samsung C&T consists of 4 business groups, which are Engineering & Construction, Trading & Investment, Fashion, Resort, and owns Samsung Welstory (Food & Beverage) and Samsung Biologics (CMO) as subsidiaries to secure management stability and sustainable growth of businesses.
· E&C: Building, civil infrastructure, plant, residential housing, and growth driver (energy solutions, investment/development, home/building platform) businesses
· T&I: Development and operation of renewable energy projects, trading of industrial materials and tech products (semiconductors/bio), etc.
· Fashion: Operates a portfolio of 39 brands across menswear, womenswear, SPA, and imported brands
· Resort: Theme parks, golf country clubs, and landscaping business
For further information, please refer to the [Business] section.
Samsung C&T's corporate bonds and commercial paper are rated by Korea's 3 major credit rating agencies - Korea Rating Corporation, NICE Information Service, and Korea Investors Service - and Samsung C&T is maintaining AA+ and A1 ratings respectively.
For overseas credit ratings, C&T is maintaining A- (Stable) for the long-term credit rating from the global credit rating agency S&P and A2 (Stable) from Moody's.
For further information on the past credit ratings, please refer to [IR > Financial Information > Credit Rating].
Samsung Everland has evolved into a leader in Korea’s service industry by expanding its business sectors to resorts, food and beverage, etc.
In December 2013, Samsung Everland acquired the Fashion Business Group of Cheil Industries, the leading player in Korea's fashion industry since its foundation in 1954, and changed its name to Cheil Industries with a focus on designing lifestyle.
In September 2015, Cheil Industries merged Samsung C&T, a leading company in both construction and general trading industries, and changed the name to Samsung C&T. With expanded business sectors ranging from construction, trading to fashion and resort, Samsung C&T has set a new vision to become a 'Global Business Partner' and 'Lifestyle Innovator'.
For your reference, former Samsung C&T Corporation was established in 1938, which laid foundation for the rise of Samsung Group and designated by the Korean government as the nation’s “first general trading company” in 1975 to lead the nation's export drive.
Since the merger with Samsung Construction in 1995, former Samsung C&T has been actively engaged in various global businesses through offices in over 50 countries.
For further information, please refer to .[About C&T > history]
Samsung C&T's ownership structure for the common stock as of March 31, 2026 is as follows;
- Controlling shareholder and related parties 38%, Domestic institutions 14%, foreigners 30%, domestic individuals and others 18%
For further information, please refer to [IR > Stock Information > Ownership Structure].
As of March 31, 2026, total number of shares issued by Samsung C&T is 163,636,571 shares. Of the total volume, 162,168,981 shares are common stock and 1,467,590 shares are preferred stock.
※ For your information, the listing date of the new shares issued after the merger is September 15, 2015.
Samsung C&T wholly owns Samsung Welstory—its food & beverage subsidiary—and holds approximately 43% of Samsung Biologics and approximately 43% of Samsung Epis Holdings, a bio investment holding company.
Samsung Epis Holdings wholly owns Samsung BioEpis, a biosimilar and new drug development company, and EPIS NexLab, a next-generation biotechnology company.
Generally, dividends are paid within 1 month after the BOD approves the financial statements, including the total dividend amount, at the annual general meeting of shareholders, to the registered shareholders as of the end of December, as stipulated in the relevant regulations.
At the annual general meeting of shareholders on March 20, 2026, the annual financial statements including the total dividend amount (KRW 2,800 per common share, KRW 2,850 per preferred share), were approved.
ㆍPeriod: July 24, 2015 – October 8, 2015
ㆍRepurchased shares: 2.5 million shares, KRW 409 billion
Finalcial related Where can I find Samsung C&T´s financial statements and other financial information?
You can download Samsung C&T's condensed financial statements, audit reports and other financial information at 'Financial Information' section of the home page.
Please click the below link.
- [IR > Financial Information > Financial Snapshot]
- [IR > Financial Information > Audited & Non-Audited Financial Statements]
Samsung C&T usually makes quarterly earnings announcement at the end of following month of every quarter's end, shortly after the approval of quarterly financial statements by the BOD.
- This means earnings release for the 1Q will be in April, 2Q in July, 3Q in October, 4Q in next year's January.
For the exact date of the quarterly earnings release, please check [IR > IR Events & Earnings Release] about 2 weeks before the estimated time of the date.



